To Homepage
  • Product lines
    • Overview
    • B·R·A·H·M·S PCT (Procalcitonin)
    • Prenatal Screening
      • Complete Portfolio
      • Products & Assays
      • 1st Trimester Pre-eclampsia Screening
      • Pre-eclampsia Diagnosis & Prognosis
      • Cell free DNA Prenatal Screening
      • Media & Material
      • PNS Forum Berlin
      • Prenatal Screening Webinars
    • Oncology
      • CgA II in Prostate Cancer
      • Webinar: Prostate Cancer Biomarkers
    • Endocrinology
      • TRAK human
    • MR-proADM
      • Adrenomedullin
      • B·R·A·H·M·S MR-proADM
      • Sepsis in the ICU
      • Infection in the ED
    • Copeptin proAVP
      • About Copeptin
      • Copeptin in Cardiology
      • Copeptin in Endocrinology
      • Diagnostic Algorithms
      • Product Brochures
      • Videos about Copeptin
      • Request Free Booklet
    • KRYPTOR Analyzers
      • Benefits & Features
      • KRYPTOR GOLD
      • KRYPTOR compact PLUS
      • TRACE Technology
      • Self-determining Dilution Factor
      • Indications
  • Customer Service
  • Events
    • World Pre-eclampsia Day
  • News & Media
    • News
    • Videos
    • On-Demand Webinar Library
  • About B·R·A·H·M·S
    • Mission
    • Electronic Instructions for Use (IFU)
    • Quality & Reliability
    • Research & Development
    • Intellectual Property (IP)
      • Patents
    • Medical Affairs
    • Business Development
  • Contact
  • Overview
  • B·R·A·H·M·S PCT (Procalcitonin)
  • Prenatal Screening
    • Complete Portfolio
    • Products & Assays
    • 1st Trimester Pre-eclampsia Screening
    • Pre-eclampsia Diagnosis & Prognosis
    • Cell free DNA Prenatal Screening
    • Media & Material
    • PNS Forum Berlin
      • Recorded Session 2020
    • Prenatal Screening Webinars
  • Oncology
  • Endocrinology
  • MR-proADM
  • Copeptin proAVP
  • KRYPTOR Analyzers
  • You are here:  
  • Home
  • Product lines
  • Prenatal Screening
  • PNS Forum Berlin

International Workshop on Prenatal Screening

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017

2021

Clinical implementation of first trimester pre-eclampsia screening

Duration: 1,5 h

The presentation focus will be on clinical implementation of first trimester pre-eclampsia screening in different set-ups and countries. You will have the possibility to interact live with 5 of the most outstanding professionals in prenatal screening and address your questions directly to the experts.

Agenda

  • Welcome from Chairman
    Prof. Kevin Spencer
    Former Consultant Biochemist & Clinical Lead, Kings George Hospital, London, UK
  • Ultrasound aspects and implementation in Hong Kong
    Dr. Liona Poon
    Professor (Clinical), Prince of Wales Hospital, Hong Kong
  • Lab perspective and implementation in Toulouse
    Dr. Safouane Hamdi
    Assistant-Professor of Hormonology and Senior Researcher at the Research Group on Human Fertility Toulouse University, France
  • Health economic aspects and implementation in Dresden
    Prof. Cahit Birdir
    Head of Obstetrics and Prenatal Medicine, Universitätsfrauenklinik Dresden, Germany
  • Implementation and effectiveness of early PE screening in London
    Prof. Basky Thilaganathan
    Professor in Fetal Medicine and Consultant Obstetrician and Director, Fetal Medicine Unit St Georges, St George’s Hospital, London, UK
  • Closing

 

Let’s stay connected!

Continue receiving Thermo Fisher Scientific emails and content by clicking the Subscribe button below.

Subscribe now !

Learn more about pre-eclampsia >

 

2020

Pre-eclampsia management throughout pregnancy
in times of COVID-19

prenatal-screening-webinar-2020

The webinar held on June 17th, 2020 at 4:00pm CET

This webinar provided the latest scientific information on pre-eclampsia screening and its management throughout pregnancy – especially in the current period of COVID-19.

Speakers

webinar-pre-eclampsia-screening-speaker-birdirDr. C. Birdir, University Hospital Dresden, Germany
Implementing first trimester pre-eclampsia screening in a model region in Germany

Watch recorded session >

 

webinar-pre-eclampsia-screening-speaker-verlohrenProf. S. Verlohren, Charité Berlin, Germany
How to deal with high risk pre-eclampsia pregnancies in the times of COVID-19

Due to confidential agreements we cannot provide the presentation of Prof. Verlohren and we do hope for your understanding.

2019

                        

11th International Workshop on Prenatal Screening - Berlin 2019

We are very pleased to share the following lectures as pdf files.

 

State of the art of first trimester preeclampsia screening - Pr. da Costa

Download presentation >

   

KRYPTOR GOLD / Inhibin A: FMF certification
Dr. Jones

Download presentation >

   

Patients view / World PE day
Mrs. Mader 

Download presentation >

   

Contingent screening / NIPT guidelines
Pr. Birdir 

Download presentation >

   

Great obstetrical syndromes: screening and prevention - Pr. Bujold

Download presentation >

   

FMF concept of pre-eclampsia and IUGR screening throughout pregnancy - Dr. Döbert

Download presentation >

   

1st trimester pre-eclampsia screening: implementation into routine - Dr. de Paco

Download presentation >
   

Screening and prevention for late-onset PE: STATIN trial - Dr. Panaitescu

Download presentation >

2018

                                          

10th International Workshop on Prenatal Screening - Berlin 2018

We are very pleased to share the following lectures as pdf files.

 

Preeclampsia screening: time for implementation - Dr. Mar Gil

Download presentation >

   

The Danish PNS program: including pre-eclampsia and NIPT - Dr. Petersen

Download presentation >

   

Counselling patients in times of NIPT - Prof. Kozlowski

Download presentation >

   

1st trimester pre-eclampsia screening: PREVAL study - Dr. Santacruz

Download presentation >

   

3rd trimester pre-eclampsia screening: STATIN study - Dr. Döbert

Download presentation >

   

Health economic aspects of preeclampsia management - Prof. Stepan

Download presentation >

   

Guidelines on preeclampsia management - Dr. Verlohren

Download presentation >
   

Quiz (FMF algorithm on adverse outcomes other than T21) - Prof. Kagan

Download presentation >

2017

                                          

9th International Workshop on Prenatal Screening - Berlin 2017

We are very pleased to share most of the lectures as pdf files and videos.

 

Ensuring high quality NIPT

There is a lack of external quality control scheme for cfDNA prenatal tests. Dr. Deans, the scheme director of UK NEQAS, introduces the EQA pilot project.

Download presentation >  

 

 

 

 

Contingent Model in Switzerland

Prof. Dr. Tercanli shares experience of cfDNA and contingent screening implementation in Switzerland, discusses results and learnings for the last year.

Download presentation >

 

 

 

 

Cell-free DNA FMF contingent screening

Dr.Gil presents FMF studies about performance of cfDNA/NIPT test, screened conditions, interpretation of results and a model of clinical implementation.

Download presentation >

 

 

 

 

Prediction of stillbirth

Prof. Akolekar describes methods and performance of stillbirth screening.

Download presentation >

 

 

 

 

Screening for pre-eclampsia in 2nd and 3rd trimesters

Prof. Birdir describes a way to screen for late-onset form of preeclampsia in routine population around week 34.

Download presentation >

 

 

 

 

Pyramid of care – Importance of ultrasound

Prof. Kagan describes a first trimester screening approach in weeks 11-13 to detect pregnancy complications as trisomies, preeclampsia, IUGR, preterm birth.

Download presentation >

 

 

 

 

Implementing pre-eclampsia screening - Czech experience

Prof. Lubusky describes the way preeclampsia screening is performed at his university clinic in Czech Republic.

Download presentation >

 
  • thermo scientific
  • applied biosystems
  • invitrogen
  • fisher scientific
  • unity lab service
  • Product Lines
    • Overview
    • B·R·A·H·M·S PCT
    • Prenatal Screening
    • Oncology
    • Endocrinology
    • MR-proADM
    • Copeptin proAVP
    • KRYPTOR Instruments
  • About B·R·A·H·M·S
    • Mission
    • Electronic Instructions for Use (IFU)
    • Quality & Reliability
    • Research & Development
    • Intellectual Property (IP)
    • Medical Affairs
    • Business Development
  • Customer Service
    • Events
    • News & Media
    • Contact
  • Imprint
  • Disclaimer
  • Privacy Statement
  • Terms & Conditions
  • Legal Entities
  • Cookie Usage
  • Trademarks
  • Patents
  • Career

© 2022 Thermo Fisher Scientific Inc. All Rights Reserved.

Not all products are CE marked or have 510(k) clearance for sale in the U.S. Availability of products in each country depends on local regulatory marketing authorization status.